Send to a friend

Important Safety Information and Indication for Prevnar 13^®

Important Safety Information

Prevnar 13^® should not be given to anyone with a history of severe allergic reaction to any component of Prevnar 13^® or any diphtheria toxoid–containing vaccine
Children with weakened immune systems (eg, HIV infection, leukemia) may have a reduced immune response
A temporary pause of breathing following vaccination has been observed in some infants born prematurely

The most commonly reported serious adverse events in infants and toddlers were bronchiolitis (an infection of the lungs) (0.9%), gastroenteritis (inflammation of the stomach and small intestine) (0.9%), and pneumonia (0.9%)
In children 6 weeks through 17 years, the most common side effects were tenderness, redness, or swelling at the injection site, irritability, decreased appetite, decreased or increased sleep, and fever
Ask your healthcare provider about the risks and benefits of Prevnar 13^®. Only a healthcare provider can decide if Prevnar 13^® is right for your child

Patients should always ask their doctors for medical advice about adverse events. You are encouraged to report negative side effects of vaccines to the US Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC). Visit www.vaers.hhs.gov or call 1-800-822-7967.

Indication for Prevnar 13^®

Prevnar 13^® is a vaccine approved for children 6 weeks through 17 years of age for the prevention of invasive disease caused by 13 Streptococcus pneumoniae strains (1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F), and for children 6 weeks through 5 years for the prevention of otitis media caused by 7 of the 13 strains
Prevnar 13^® is not 100% effective and will only help protect against the 13 strains included in the vaccine

Please see full Prescribing Information.

Indication for Prevnar 13^®

SELECTED SAFETY INFORMATION

Indication for Prevnar 13^®

SELECTED SAFETY INFORMATION

Send to a friend

Indication for Prevnar 13®

SELECTED SAFETY INFORMATION

Send to a friend

Indication for Prevnar 13^®